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The unfolded protein response (UPR) is a signaling
pathway required to maintain endoplasmic reticulum
(ER) homeostasis and hepatic lipid metabolism.
Here, we identify an essential role for the inositol-
requiring transmembrane kinase/endoribonuclease
1a (IRE1a)-X box binding protein 1 (XBP1) arm of
the UPR in regulation of hepatic very low-density
lipoprotein (VLDL) assembly and secretion. Hepato-
cyte-specific deletion of Ire1a reduces lipid partition-
ing into the ER lumen and impairs the assembly of
triglyceride (TG)-rich VLDL but does not affect TG
synthesis, de novo lipogenesis, or the synthesis or
secretion of apolipoprotein B (apoB). The defect in
VLDL assembly is, at least in part, due to decreased
microsomal triglyceride-transfer protein (MTP)
activity resulting from reduced protein disulfide
isomerase (PDI) expression. Collectively, our find-
ings reveal a key role for the IRE1a-XBP1s-PDI axis
in linking ER homeostasis with regulation of VLDL
production and hepatic lipid homeostasis that may
provide a therapeutic target for disorders of lipid
metabolism.
INTRODUCTION
Hepatic very low-density lipoprotein (VLDL) secretion plays an
essential role in regulating intrahepatic and plasma lipid homeo-
stasis (Bamba and Rader, 2007). Elevated production of hepatic
VLDL is a common cause of dyslipidemia and is tightly associ-
ated with an increased risk of cardiovascular disease, especially
for individuals with obesity and type 2 diabetes (Adiels et al.,
2008). The mechanism underlying dysregulation of hepatic
VLDL production is not completely understood, and new factorsCellplaying critical roles in this process are still emerging (Calandra
et al., 2011; Chen et al., 2010).
The ER is themajor site for lipid synthesis and VLDL assembly.
ER homeostasis is maintained by an adaptive mechanism
termed the unfolded protein response (UPR) through inositol-
requiring transmembrane kinase/endoribonuclease 1a (IRE1a),
protein kinase R (PKR)-like ER kinase (PERK), and activating
transcription factor 6 (ATF6a). Disturbed ER homeostasis can
stimulate lipogenesis (Kammoun et al., 2009) and inhibit hepatic
VLDL secretion (Ota et al., 2008; Qiu et al., 2006), resulting in
hepatosteatosis. Although each arm of the UPR is required to
alleviate hepatosteatosis under pharmacologically induced,
extreme levels of ER stress (Rutkowski et al., 2008), the specific
contribution of each individual UPR pathway to either hepatic
VLDL production and/or plasma lipoprotein metabolism under
physiological conditions is an important understudied problem.
Recently, it was shown that CREB-H, regulated through ER
stress-induced intramembrane proteolysis (Zhang et al., 2006),
similar to ATF6, acts to decrease plasma triglycerides (Zhang
et al., 2012) and that defective CREB-H alleles in humans asso-
ciate with extreme hypertriglyceridemia, supporting the physio-
logical significance of CREB-H in lipid homeostasis (Lee et al.,
2011).
Hepatic VLDL assembly is a two-stage process (Sundaram
and Yao, 2010). In the initial stage, the apolipoprotein B (apoB)
is synthesized in the rough ER (rER) by cotranslational lipidation
upon translocation into the rER lumen. In the second stage,
bulk neutral lipids, especially triglycerides (TGs), are added to
the VLDL precursors in the lumen of the smooth ER (sER) and/or
theGolgi apparatus to form lipid-rich VLDL (Rusin˜ol et al., 1993).
ApoB is an obligate structural component of VLDL, whereas the
microsomal TG-transfer protein complex (MTP) is a cofactor
that is absolutely required at both stages of VLDL biogenesis
(Hussain et al., 2003). Protein disulfide isomerase (PDI) is
a subunit of MTP necessary for normal MTP activity (Wetterau
et al., 1991). Numerous studies demonstrate that increased ex-
pression of MTP elevates MTP activity and VLDL secretion, but
a similar role for PDI hasnot beendemonstrated (Pan et al., 2010).Metabolism 16, 473–486, October 3, 2012 ª2012 Elsevier Inc. 473
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IRE1a Regulates Hepatic VLDL Assembly and SecretionTGs stored in cytosolic lipid droplets (CLDs) are the major
source of lipid substrates for VLDL assembly (Yang et al.,
1995). It is believed that cytosolic TG undergoes lypolysis (in
the cytosol) and reesterification (in ER membranes) for delivery
to the ER lumen for VLDL assembly (Lankester et al., 1998).
Themechanism(s) that controls partitioning of newly synthesized
TG between the cytosol and the ER lumen is poorly understood.
Due to its lipid transfer activity, MTP is thought to play a critical
role in facilitating the accretion of lumenal TG (Raabe et al.,
1999). Although studies demonstrate that ER stress interferes
with hepatic lipid homeostasis, it is unknown whether the UPR
pathways affect the lipid partitioning process and/or VLDL
assembly.
IRE1a plays an essential role in maintaining ER homeostasis
through initiating unconventional splicing of XBP1 mRNA to re-
move a 26 base intron, to create a translational frameshift in
XBP1 mRNA to produce a potent transcription factor (XBP1s)
that regulates expression of genes encoding functions in ER
protein folding and trafficking and ER-associated degradation
to preserve ER homeostasis (Lee et al., 2002). Recently,
XBP1s was shown to induce key hepatic lipogenic genes (Lee
et al., 2008). It was reported that Xbp1 deletion in the liver
reduces hepatic lipogenesis and leads to hypolipidemia in
mice (Lee et al., 2008).
To determine the role of the IRE1a-XBP1 axis in regulation of
hepatic metabolism, we generated hepatocye-specific Ire1a-
deleted mice (Zhang et al., 2011). Thesemice did not show basal
UPR activation or any noticeable developmental or morpholog-
ical abnormalities but developed severe hepatosteatosis upon
pharmacologically induced ER stress (Zhang et al., 2011). The
present study was aimed at elucidating the role of the IRE1a
axis in hepatic lipid metabolism under physiological conditions
of metabolic stress. We demonstrate that Ire1a deletion in hepa-
tocytes does not affect hepatic lipogenesis but impairs assembly
of VLDL in the ER, leading to decreased hepatic export of
TG-rich VLDL and increased hepatic TG accumulation. Impaired
VLDL assembly occurs as a result of a reduced accumulation of
TG in the ER lumen, due at least in part to deceasedMTP activity
resulting from decreased expression of PDI. This study demon-
strates that the IRE1a-XBP1s-PDI axis plays a fundamental
physiologic role to link ER homeostasis with MTP activity and
VLDL assembly.
RESULTS
Hepatocyte-Specific Ire1a Deletion Accentuates
Nutritional Stress-Induced Hepatosteatosis without
Affecting De Novo Lipogenesis
Lethality of germline-deleted Ire1a null mice prompted us to
generate a conditional allele to study the physiological functions
of IRE1a in the murine liver. The hepatocyte (liver)-specific Ire1a
null (herein called L-Ire1a-KO) mice and their littermate heterozy-
gous (herein called L-Ire1a-Het) or wild-type (L-Ire1a-WT) mice
were generated by crossing homozygous Ire1a-floxed mice
with the compound heterozygous Ire1a null mice containing
Cre recombinase under the control of albumin promoter (Zhang
et al., 2011). The resultant L-Ire1a-KOmice permit efficient CRE-
mediated deletion of the single Ire1a-floxed allele in the liver of
Ire1a null heterozygous mice (Zhang et al., 2011). We have not474 Cell Metabolism 16, 473–486, October 3, 2012 ª2012 Elsevier Inobserved any difference in liver function and plasma lipid param-
eters between L-Ire1a-Het and L-Ire1a-WT mice. We assessed
the physiologic role of IRE1a in regulation of hepatic lipid homeo-
stasis by comparing L-Ire1a-KO with littermate L-Ire1a-Het
and/or L-Ire1a-WTmice. We first investigated the effect of hepa-
tocyte-specific Ire1a deletion on hepatosteatosis induced by
either fasting or overnutrition.
L-Ire1a-KO mice displayed only mild hepatosteatosis when
fed normal chow; however, upon a 16 hr fast they exhibit a
2-fold increase in hepatic TG content compared to L-Ire1a-Het
mice (Figures 1A and 1B). Cholesterol ester (CE) levels were
also elevated in L-Ire1a-KO mice under fasted conditions
(Figures 1A and 1B). An increased delivery of adipose tissue-
derived free fatty acids (FFAs) to the liver is a key mechanism
of fasting-induced hepatostatosis in mice. However, deletion
of Ire1a in hepatocytes did not alter plasma FFA levels under
either fed or fasting conditions (see Figure S1A online), indicating
that hepatic uptake of FFA from plasma is unlikely to contribute
to the difference in hepatic lipid accumulation observed between
L-Ire1a-Het and L-Ire1a-KO mice.
We next fed mice with a high-fructose diet (HFD) to study the
effects of overnutrition on hepatic lipid homeostasis. This diet
stimulates de novo lipogenesis and causes lipid accumulation
in the liver (Fukuda et al., 1983). Most of the metabolic parame-
ters were comparable between L-Ire1a-KO and L-Ire1a-Het
mice after a 12 week HFD-feeding period (Table S1). Insulin
signaling was also similar between these mice (Figures S1B–
S1D). However, the L-Ire1a-KO livers were substantially more
steatotic than livers from L-Ire1a-Het mice at every time point
examined during feeding of HFD (Figures 1C and 1D). These
findings suggest that L-Ire1a-KO hepatocytesmay have a defect
in disposing of FFA derived from de novo lipogenesis.
Since it was reported that Xbp1 deletion impaired hepatic
lipogenesis (Lee et al., 2008), we were surprised to find that
L-Ire1a-KO mice display an augmented steatotic phenotype.
To address this issue, we first analyzed gene expression of key
lipogenic transcription factors, including liver X receptor (LXR),
SREBP-1c, and the carbohydrate response element binding
protein (ChREBP). There were no differences in the expression
levels of these genes between the two groups of mice (Fig-
ure S1E). In addition, although mRNA levels of lipogenic
genes, including Scd1, Acc, and Fasn, were moderately attenu-
ated in L-Ire1a-KOmice (Figure 1E), their protein levels were not
altered (Figure 1F). Moreover, metabolic labeling experiments
using hepatocytes confirmed that Ire1a deletion did not alter
de novo lipogenesis (Figure 1G). Thus, the previously reported
effect of Xbp1 deletion on lipogenesis was not observed in
L-Ire1a-KO mice.
Mitochondrial b-oxidation of fatty acids and VLDL secretion
are the primary catabolic pathways by which the liver maintains
fatty acid homeostasis. However, we found no difference in the
expression of key genes in the fatty acid oxidation pathway
including the peroxisome proliferator-activated receptor (Ppara)
and acyl-CoA oxidase (Acox) and carnitine palmitoyltransferase-
1a (Cpt1) between L-Ire1a-KO and L-Ire1-Hetmice (Figure S2A).
Furthermore, the rate of [3H]-palmitic acid oxidation was not
altered due to Ire1a-deletion in hepatocytes (Figure S2B).
In addition, there were no significant differences in plasma
ketone body levels between L-Ire1a-KO and L-Ire1-Het micec.
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Figure 1. Hepatocyte Specific Ire1a Deletion Accentuates Nutritional Stress Induced Hepatosteatosis without Affecting De Novo
Lipogenesis
(A and B) A 16 hr fast increases lipid accumulation in L Ire1a KO livers. (A) Liver TG and cholesterol esters weremeasured from L Ire1a Het and L Ire1a KOmice,
in fed and 16 hr fasted conditions, n = 4. *p < 0.01 versus L Ire1a KO. (B) Micrographs of liver sections frommice that were fed or fasted for 16 hr were stained with
hematoxylin and eosin (H&E). Scale bars, 40 mm.
(CandD) Ahigh fructose diet (HFD) increases TGaccumulation inL Ire1a KOmice. (C) Liver TGwasmeasured inmice fedwithHFD for the indicated times (nR4).
*p < 0.05 versus L Ire1a Het. (D) Mice were fed with HFD for indicated time periods and liver sections prepared and stained with H&E. Scale bars, 30 mm.
(E and F) Livers frommice fed a HFD were analyzed for mRNA and proteins levels of lipogenic genes. (E) The abundance of lipogenic genemRNAwas normalized
to actin mRNA. Values are relative to mRNA levels of L Ire1a Hetmice fed with chow. (F) Liver lysates were prepared from mice fed with chow (Co) or HFD (HF)
and analyzed by immunoblotting. Calnexin was used as a loading control.
(G) Fatty acid synthesis was measured in hepatocytes by labeling with [14C] acetic acid for 4 hr (n = 6).
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IRE1a Regulates Hepatic VLDL Assembly and Secretion(Figure S2B). Taken together, these results indicate that the
decreased capacity of the L-Ire1a-KO livers to handle the
increased amounts of hepatic fatty acids during long-term fast-
ing or feeding of HFD was not due to impaired fatty acid
oxidation, pointing to a possible defect in hepatic TG export in
these mice.CellHepatocyte-Specific Ire1a-Deleted Mice Display
Hypolipidemia and Reduced Hepatic VLDL-TG Secretion
To investigate the potential effect of Ire1a deletion on hepatic
VLDL production, we first measured plasma lipid levels under
fed and fasted conditions. Plasma TG levels were reduced
40% in long-term fasted L-Ire1a-KO mice than L-Ire1a-HetMetabolism 16, 473–486, October 3, 2012 ª2012 Elsevier Inc. 475
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Figure 2. Hepatocyte Specific Ire1a Deleted
Mice Display Hypolipidemia and Reduced
Hepatic VLDL Secretion
(A) Plasma TG and cholesterol levels are reduced
in L Ire1a KO mice. Levels of plasma TG and
cholesterol were measured in fed and 16 hr fasted
mice, n > 40. *p < 0.01 versus L Ire1a Het.
(B and C) Plasma VLDL TG and HDL cholesterol
levels are reduced in L Ire1a KO mice.
(D and E) VLDL TG secretion is reduced in
L Ire1a KO mice. Mice (n R 5) fed with chow or
HFD for 2 days were fasted 4 hr followed by
i.v. injection with tyloxapol. *p < 0.05 versus
L Ire1a Het.
(F) Plasma levels of apoB from the ‘‘0’’ time point to
120 min in Figure 2D were measured.
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IRE1a Regulates Hepatic VLDL Assembly and Secretionmice (Figure 2A). The decreased plasma TG levels were also
observed in short-term fasted L-Ire1a-KO mice (Figure S2C).
Plasma cholesterol levels were substantially decreased in both
fed and long-term fasted L-Ire1a-KO compared to L-Ire1a-Het
mice. Fast protein liquid chromatography (FPLC) analysis
demonstrated that these changes in plasma lipids were mainly
due to decreases in VLDL-TG and HDL-cholesterol levels in476 Cell Metabolism 16, 473–486, October 3, 2012 ª2012 Elsevier Inc.L-Ire1a-KO mice (Figures 2B and 2C).
The decrease in VLDL-TG level sug-
gested defective secretion of hepatic
VLDL in these mice.
We measured hepatic VLDL secretion
by injecting mice with tyloxapol to
inhibit VLDL catabolism. Accumulation
of plasma TG was significantly less in
L-Ire1a-KO mice than L-Ire1a-Het mice
after tyloxapol injection (Figure 2D),
leading to a 40% decrease in the rates
of hepatic VLDL-TG secretion (Figure 2E).
In contrast to the decreased hepatic
VLDL-TG secretion, there was no pheno-
typic difference in the plasma levels of
apoB before or after tyloxapol injection
(Figure 2F and Figures S2D and S2E),
suggesting that the apoB-containing lipo-
protein particles secreted from the livers
of L-Ire1a-KO have reduced TG content.
Ire1a Deletion Impairs Secretion of
TG-Rich VLDL Particles
We next labeled hepatocytes with [3H]-
glycerol to examine the effect of Ire1a
deletion on TG synthesis and TG secre-
tion. Under basal conditions where intra-
cellular TG is mainly derived from de
novo lipogenesis or amorephysiologically
relevant condition with oleic acid (OA)
supplementation, there was no difference
in TG synthesis between hepatocytes iso-
lated from the two groups of mice (Fig-
ure3A). Thesefindings reinforce thenotion
that Ire1a deletion does not alter lipogen-esis. However, the rate of TG secretion was significantly reduced
in L-Ire1a-KO hepatocytes (Figure 3B) under both conditions.
We also performed pulse-chase analysis to compare rates of
apoB synthesis and secretion between L-Ire1a-Het and L-Ire1a-
KO hepatocytes in the presence of OA. Murine hepatocytes
predominantly produce apoB48 over apoB100, but prolonged
culture in vitro increases the ratio of apoB100 to apoB48, most
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Figure 3. Ire1a Deletion Impairs Secretion of TG Rich VLDL Particles
(A and B) TG secretion is reduced without a change in TG synthesis in L Ire1a KO hepatocytes. Hepatocytes were labeled with [3H] glycerol in the presence of
BSA or OA for 3 hr, and intracellular (A) and secreted (B) was measured (n = 6). *p < 0.05 versus L Ire1a Het hepatocytes.
(C) ApoB synthesis and secretion are not altered in L Ire1a KO hepatocytes. Primary hepatocytes were incubated for 48 hr in vitro and then pulse labeled with
[35S] Met/Cys for 20 min. Intracellular apoB and secreted apoB were analyzed by immunoprecipitation and SDS PAGE.
(D) Secretion of lipid rich apoB particles is reduced in L Ire1a KO hepatocytes. Secreted apoB containing lipoproteins from hepatocytes were analyzed by
DGUC and immunoblotting (n = 3). The abundance of apoB in each fraction was quantified by ImageJ, and relative amounts were calculated from the percentage
of intensity in each fraction relative to the total intensity across the gel. *p < 0.05 versus L Ire1a Het hepatocytes.
(E) VLDL assembly is defective in L Ire1a KO ER lumen. Lumenal apoB was analyzed by DGUC (n = 3). Fractions were either immunoprecipitated with
anti apoB antibody or concentrated and analyzed by immunoblotting for MTP and apoE. The analysis was quantified as described in (D). *p < 0.05 versus
L Ire1a Het.
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IRE1a Regulates Hepatic VLDL Assembly and Secretionlikely due to the decreased apoB RNA editing activity that
accompanies dedifferentiation. To examine the synthesis and
secretion of apoB48, as well as apoB100, we conducted
pulse-chase analysis in primary hepatocytes, after an overnight
(Figure S3B) or a 2 day culture period (Figure 3C). Neither the
synthesis nor secretion of apoB48 or apoB100 was altered in
L-Ire1a-KO hepatocytes (Figure 3C and Figures S3A and S3B).
Under these experimental conditions, we noticed very little
degradation of either apoB isoform from either L-Ire1a-Het or
L-Ire1a-KO hepatocytes (Figure S3A). Accordingly, these obser-
vations suggest that hepatocytes from both genotypes secrete
similar amounts of apoB-containing lipoprotein particles. In
addition, the secretion of albumin was also comparable between
the genotypes. These results together demonstrate that the
secretory pathway is generally intact in L-Ire1a-KO hepatocytes.
To determine the effect of Ire1a deletion on the density of
secreted VLDL particles, we performed density gradient ultra-
centrifugation (DGUC) to fractionate apoB-containing lipopro-
teins secreted into the media from hepatocytes after a 3 hr
continuous labeling with [35S]-Met/Cys and analyzed the relative
density distribution of the labeled apoB. The amount of apoB48
in lipid-rich VLDL fractions decreased50%, and the amount of
apoB48 in lipid-poor particles correspondingly increased in
L-Ire1a-KO hepatocytes (Figure 3D). Although Ire1a deletion
did not affect apoB100 lipidation to the same extent as
apoB48 lipidation, more apoB100 did reside in lipid-rich particles
from L-Ire1a-Het hepatocytes than from L-Ire1a-KO hepato-
cytes (Figure 3D). Taken together, the results suggest that
Ire1a deletion specifically impairs the ability of hepatocytes to
assemble or/and secrete lipid-rich VLDL particles.
Ire1a Deletion Impairs Assembly of Lipid-Rich VLDL
Particles in the sER
The ER is the major site for VLDL assembly in hepatocytes. To
directly determine whether the defective VLDL secretion in
Ire1a-deleted hepatocytes reflects a reduced ability to assemble
lipid-rich VLDL particles in the ER, we conducted DGUC exper-
iments on ER lumenal extracts to separate the lipoprotein
complexes based on their buoyant densities that reflect lipid
content. Approximately 10% of both apoB48 and apoB100
was present in the lipid-rich fraction from the ER lumen of
L-Ire1a-Hetmice (Figure 3E), and the abundance of each isoform
significantly decreased to5% in the ER lumen from L-Ire1a-KO
mice (Fraction 1 in Figure 3E). Correspondingly, the levels of
apoB in lipid-poor fractions increased in the L-Ire1a-KO ER
lumen (Figure 3E). Although the distribution of both apoB48Figure 4. Ire1a Deletion Reduces TG Content in the sER of the Liver
(A and B) Complementation of IRE1a or spliced XBP1 (XBP1s) restores TG s
were measured by immunoblotting of hepatocytes infected with adenoviruses ex
kinase dead IRE1a (Ad IRE599), or RNase dead IRE1a (Ad IRE907) (n = 6). (B) R
and L Ire1a KO hepatocytes infected with the above adenoviruses (n = 6). *p < 0
(C) Shown are electron micrographs of isolated rER and sER from livers.
(D) Immunoblotting analysis of protein markers was performed on isolated cellul
(E) TG accumulation is reduced in L Ire1a KO sER. Levels of TGs, cholesterol este
(n = 4). *p < 0.05 versus L Ire1a Het.
(F) ER localized TG is reduced in L Ire1a KO hepatocytes. Hepatocytes were inc
ER was isolated from 53 106 hepatocytes, and radioactivity incorporated into TG
cellular radioactivity incorporation (n = 4). *p < 0.05 versus L Ire1a Het.
(G) FAME samples derived from sER TG and non sER TG were analyzed by GC
Celland apoB100 shifted toward the lipid-poor fractions in the
L-Ire1a-KO ER lumen, the distribution of apoE shifted only
slightly toward the lipid-poor fractions, and MTP was concen-
trated in lipid-poor fractions. These observations collectively
indicate that decreased secretion of TG-rich VLDL particles
results from impaired assembly of these lipoprotein particles in
the ER lumen of L-Ire1a-KO mice.
We next analyzed expression of genes encoding currently
known protein factors affecting VLDL assembly, including Mtp,
apoE, apoC3, ADRP, CideB, PGC-1a, and PGC-1b. There
were no changes in expression of these genes (Figures S2D
and S3C). There was also no change in the expression of other
genes encoding proteins modulating hepatic TG storage, such
as PPARg, CideA, and CideC (Figure S3C), suggesting that
IRE1a regulates VLDL assembly through pathways that do not
involve regulation of these genes.
XBP1s Complementation Restores TG Secretion
in Ire1a-Deleted Hepatocytes
IRE1a directly initiates unconventional splicing of XBP1 mRNA.
To assess the specific contribution of XBP1s to the defective
VLDL secretion in L-Ire1a-KO hepatocytes, we overexpressed
XBP1s, wild-type IRE1a, kinase-dead IRE1a (K599A), and
RNase-dead IRE1a (K907A) individually using adenovirus to
test whether expression of these proteins can restore TG secre-
tion in L-Ire1a-KO hepatocytes. Overexpression of wild-type
IRE1a, but not kinase-dead IRE1a or RNase-dead IRE1a,
increased expression of XBP1s, as expected (Figure 4A). Forced
expression of XBP1s yielded significantly greater levels of
XBP1s. The amount of TG secreted by L-Ire1a-KO hepatocytes
infected with adenovirus expressing either wild-type IRE1a or
XBP1s was comparable to that secreted by L-Ire1a-Het hepato-
cytes, which was at least 30% higher than that secreted from
L-Ire1a-KO hepatocytes infected with adenovirus expressing
GFP, kinase-dead IRE1a, or RNase-dead IRE1a (Figure 4B).
Overexpression of these proteins did not affect TG synthesis
(Figure 4B) or lipogenic gene expression (Figure S4A). These
observations demonstrate that IRE1a-mediated splicing of
XBP1 mRNA corrects the defective TG secretion in L-Ire1a-KO
hepatocytes. Thus, the defective TG secretion in L-Ire1a-KO
hepatocytes was primarily due to a lack of XBP1s.
Ire1a Deletion Reduces TG Content in the sER
of the Liver
Given that VLDL assembly is highly dependent on availability
of TG in the ER, the defective assembly of VLDL particles inecretion in L Ire1a KO hepatocytes. (A) Protein levels of XBP1s and IRE1a
pressing GFP (Ad GFP), XBP1s (Ad XBP1s), and wild type IRE1a (Ad IREwt),
ates of TG synthesis and secretion were measured in L Ire1a Het hepatocytes
.05 versus XBP1s infected hepatocytes.
ar organelles.
rs, fatty acids, and phospholipids weremeasured in sER and non sER fractions
ubated with [3H] glycerol DMEM media for 3 hr with 0.4 mM OA. [3H] labeled
was measured by TLC of ER lumenal fractions and presented relative to total
. FAME samples were isolated from four livers of each genotype.
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Figure 5. Hepatocyte Specific Ire1a Deletion Decreases PDI Levels and MTP Activity in the Liver
(A) Proteomic analysis of sER fractions was performed using IEF followed by SDS PAGE. One spot identified by the circle was subjected to mass spectrum
analysis.
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IRE1a Regulates Hepatic VLDL Assembly and SecretionL-Ire1a-KO ERmay reflect decreased lipid availability in the sER.
To test this possibility, we isolated sER from the L-Ire1a-Het and
L-Ire1a-KO livers following an established method (Gilchrist
et al., 2006) and quantified lipid contents in purified sER fraction
and the pooled fraction containing rER, Golgi, and cytosol
(designated as non-sER fractions). EM analysis showed that
the fractions were relatively homogeneous and without any
discernible morphological differences in the isolated sER or
rER between L-Ire1a-KO and L-Ire1a-Het livers (Figure 4C).
The purity of the sER was also quantified by western blotting
of proteins from different cellular organelles. The results revealed
that the contaminants from Golgi, plasma membrane, CLD, and
mitochondria were largely removed (Figure 4D). In addition, the
levels of Sec61b, a rER-specific marker (Gilchrist et al., 2006),
and epoxide hydrolase, a sER marker (Galteau et al., 1985),
were not significantly different between genotypes, suggesting
the relative mass of rER and sER was similar between L-Ire1a-
KO and L-Ire1a-Het livers.
Analysis of lipid content demonstrated that TG levels were
significantly decreased in sER fractions but increased in non-
sER fractions from L-Ire1a-KO livers (Figure 4E). Since total
sER-TG only accounted for 7% of TG in non-sER fractions,
the total intracellular TG was mainly from non-sER-TG, which
was greater in L-Ire1a-KO livers, reflecting the steatotic pheno-
type of L-Ire1a-KO mice. Interestingly, elevated levels of CE
were observed in both sER fractions and non-sER fractions
from L-Ire1a-KO livers (Figure 4E). TG and CE are major lipid
constituents in CLD; therefore, the inverse relationship between
TG and CE levels in sER fractions from L-Ire1a-KO livers
confirmed the minimal contamination of CLD in the isolated
sER fractions. Moreover, FFA levels were higher in both fractions
from L-Ire1a-KO livers compared to L-Ire1a-Het livers, which
may result from elevated lipolysis of the overaccumulated TG.
Phospholipid levels in the fractions were comparable between
the two groups of livers (Figure 4E).
To confirm that there was also a decrease in accumulation of
newly synthesized TG in L-Ire1a-KO ER, we employed [H3]-glyc-
erol labeling to measure TG partitioning between the cytosol and
the ER in L-Ire1a-Het and L-Ire1a-KO hepatocytes. Indeed, [H3]-
labeled TG in the ER from L-Ire1a-Het hepatocytes was 40%
greater than that from the L-Ire1a-KO hepatocytes (Figure 4F).
Taken together, the decreased TG content associated with
defective TG-rich VLDL assembly in the L-Ire1a-KO ER (Fig-
ure 3D) indicates that the defect in TG-rich VLDL assembly
occurs in the ER due to Ire1a deletion. However, we cannot
completely exclude the possibility that Ire1a deletion additionally
affects the process of VLDL maturation in the Golgi.
Lipid composition in the sER and non-sER fractions was
further analyzed by gas chromatography (GC). Fatty acid methyl(B) PDI levels are reduced in L Ire1a KO livers. Shown is immunoblot analysis o
intensities of PDI andMTP in the blot were quantified by ImageJ and normalized to
in each fraction from L Ire1a Het samples. The ratios of PDI and MTP in L Ire1a
L Ire1a Het samples.
(C) MTP activity is reduced in L Ire1a KO livers. MTP activity was measured in li
(D) Treatment of hepatocytes with 0.3 mMCP 100447 reduces bothMTP activity a
measured in wild type hepatocytes treated with MTP inhibitor, CP 100447.
(E) Hepatocytes treated with 0.3 mM CP 100447 reduce secretion of apoB in lip
intensities was plotted as described in Figure 3D.
Cellesters (FAMEs) derived from TG increased uniformly in the
non-sER fraction and decreased in the sER fraction from
L-Ire1a-KO livers (Figure 4G, Figures S4B and S4C). Similarly,
FAMEs of CE in both sER and non-sER fractions were elevated
in L-Ire1a-KO livers, and FAMEs of phospholipids in both sER
and non-sER fractions were comparable between L-Ire1a-KO
and L-Ire1a-Het livers (Figures S4B and S4C). We did not
observe any changes in the distribution of FFA species, suggest-
ing that IRE1a-XBP1s does not alter fatty acid composition to
reduce TG accumulation in the sER. In addition, the contents
of TG, CE, and phospholipids calculated according to the
concentration of FAMEs in the GC analysis again revealed
a reduction of TG and an increase of CE in L-Ire1a-KO sER (Fig-
ure S4B). Taken together, the observations from both enzymatic
assays and GC analysis consistently indicate that intervention in
the IRE1a-XBP1s pathway specifically reduces TG accumula-
tion in the ER, which, in turn, impairs the assembly of TG-rich
VLDL particles.
Hepatocyte-Specific Ire1a Deletion Decreases PDI
Levels and MTP Activity in the Liver
To identify the defective protein component(s) responsible for
the diminished TG accumulation in L-Ire1a-KO ER, we per-
formed microarray mRNA expression profiling (Zhang et al.,
2011) and proteomic analysis. Comparative 2D proteomic anal-
ysis on sER isolated from L-Ire1a-Het and L-Ire1a-KO livers
demonstrated that they were very similar (Figure 5A). Neverthe-
less, several protein species that had increased intensity in
L-Ire1a-Het sER compared to L-Ire1a-KO sER were isolated
for mass spectrum analysis. Interestingly, one of these species
was identified as PDI (also known as PDIa1 and prolyl 4-hydrox-
ylase subunit b). PDI was also identified in themicroarray studies
as an IRE1a-dependent target gene (Zhang et al., 2011). Given
that PDI is a structural component of MTP (Bradbury et al.,
1999), this observation raised the possibility that reduced levels
of PDI in L-Ire1a-KO hepatocytes decrease MTP activity,
affecting TG accumulation in the ER.
To test this idea, we used immunoblot analysis to quantify PDI
contents in whole-liver homogenates and ER fractions and
measured liver MTP activity. PDI levels in L-Ire1a-KO livers
were decreased to one-half of those in L-Ire1a-Het livers (Fig-
ure 5B). Importantly, MTP activity was decreased 40% in
L-Ire1a-KO livers compared to L-Ire1a-Het livers (Figure 5C),
although hepatic MTP protein levels were comparable between
L-Ire1a-KO and L-Ire1a-Het mice (Figure 5B). Taken together,
these findings revealed a reduced PDI content associated with
decreased MTP activity in L-Ire1a-KO hepatocytes.
To support our finding that the defective TG-rich VLDL secre-
tion could be due to decreased MTP activity in L-Ire1a-KOf PDI and MTP in total liver lysates (Total), ER (ER), and ER lumen (ERL). The
the intensity of apoE. The relative abundances are shown relative to PDI levels
KO livers are presented relative to their amount in respective fractions from
ver lysates (n = 5). *p < 0.01 versus L Ire1a Het.
nd TG secretion by40%.MTP activity, intracellular TG, and secreted TGwere
id rich particles. DGUC was repeated twice, and the average of the relative
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centrations of MTP inhibition by CP-100447, to reduce
MTP activity to a similar extent (40%) as that obtained upon
Ire1a deletion (Figure 5D). We found that 0.3 mM CP-100447
decreased MTP activity by 40% and significantly reduced
TG secretion but not TG synthesis (Figure 5D). In addition,
DGUC experiments demonstrated that 0.3 mM CP-100447
impaired secretion of TG-rich VLDL particles to a similar level
as observed upon Ire1a-deletion in hepatocytes (Figure 5E
and Figure 3D). Thus, these observations strengthen our conclu-
sion that decreased MTP activity at least in part contributes to
defective TG-rich VLDL assembly and secretion in L-Ire1a-KO
hepatocytes.
Overexpression of PDI but Not MTP Promotes TG
Secretion in Ire1a-Deleted Hepatocytes
To determine whether the IRE1a-XBP1s axis regulates hepatic
PDI gene expression under physiological conditions, we mea-
sured PDI mRNA levels under short fasting (Figure 6A) and fed
conditions (Figure S5A). PDI mRNA levels, together with other
XBP1-dependent UPR genes including Erdj4, Edem2, and
Wfs1, were reduced 2-fold in L-Ire1a-KO livers compared to
L-Ire1a-Het livers, whereas the expression of Bip and Grp94
and other abundant hepatic PDI family members, Erp57 and
Erp72 (Grubb et al., 2012), which are not regulated by XBP1s,
was unchanged (Figure 6A and Figure S5A). Enforced expres-
sion of XBP1s in vitro using XBP1s adenovirus markedly
increased PDI mRNA levels but not lipogenic genes in both
L-Ire1a-KO and L-Ire1a-Het hepatocytes (Figure 6B). These
observations indicate that XBP1s acts as a primary transcription
factor that regulates PDI levels in hepatocytes.
To further test whether decreased PDI is responsible for
the reduced MTP activity and defective VLDL assembly in
L-Ire1a-KO mice, we determined whether overexpression
of wild-type or mutant PDI or, alternatively, overexpression of
MTP using adenovirus can correct defective VLDL secretion in
L-Ire1a-KO hepatocytes. The mutant PDI contains four
cysteine-to-serine mutations in both of the thioredoxin-like
active sites that destroy PDI activity but retains chaperone
activity (Quan et al., 1995). Overexpression of either wild-type
or mutant PDI, but not MTP, restored MTP activity and signifi-
cantly improved TG secretion in L-Ire1a-KO hepatocytes without
affecting TG synthesis (Figures 6C–6E). These findings suggest
that the chaperone activity of PDI, but not the catalytic activity,
is required for MTP activity to rescue TG secretion in L-Ire1a-KO
hepatocytes. However, while fully restoring MTP activity, PDI
overexpression only partially restored TG secretion, suggesting
that another XBP1s-dependent factor(s) limits TG-rich VLDL
assembly in addition to PDI in L-Ire1a-KO hepatocytes.
Unlike PDI overexpression, XBP1s overexpression fully
restored not only the PDI level and MTP activity but also TG
secretion in L-Ire1a-KO hepatocytes (Figures 6C–6E), demon-
strating the importance of XBP1s in regulating VLDL assembly.
In confirmation of the immediate impact of XBP1s-PDI on TG
secretion, knockdown of XBP1 in primary hepatocytes also
decreased PDI expression, MTP activity, and TG secretion, but
not TG synthesis (Figures 6F–6H). Thus, the IRE1a-XBP1s-PDI
axis is an important regulatory pathway to maintain TG-rich
VLDL production that controls hepatic and plasma lipid content.482 Cell Metabolism 16, 473–486, October 3, 2012 ª2012 Elsevier InDISCUSSION
Accumulating evidence suggests that the UPR plays an essential
role in hepatic lipid metabolism (Flamment et al., 2010). VLDL
secretion is critical in maintaining intrahepatic and plasma lipid
homeostasis. Although ER stress was linked to dysregulation
of hepatic VLDL production (Ota et al., 2008; Qiu et al., 2006),
little is known about the mechanism by which the UPR signaling
pathways impact VLDL assembly and secretion. Here, we reveal
a specific requirement for the IRE1a-XBP1s axis in VLDL
assembly. Using L-Ire1a-KO mice, we first demonstrated that
these mice developed hepatosteatosis and hypolipidemia
primarily due to a defective TG-rich VLDL secretion. Through
metabolic labeling in primary hepatocytes, we further revealed
that reduced sER-TG accretion is a key underlying cellularmech-
anism for defective TG-rich VLDL assembly in L-Ire1a-KO hepa-
tocytes. Our studies identified no defects in lipogenesis or
apoB synthesis and secretion in L-Ire1a-KO hepatocytes. In
contrast, we show that IRE1a is required for adequate lipid
partitioning into the sER for TG-rich VLDL assembly. Finally, pro-
teomic analysis and genetic complementation approaches
demonstrated that this defect in TG-rich VLDL assembly is
caused in a large part by reducedMTP activity due to decreased
expression of PDI. Together, our study provides mechanistic
insight into the requirement for the IRE1a-XPB1s-PDI axis
in promoting TG-rich VLDL secretion and maintaining lipid
homeostasis.
VLDL assembly is highly dependent on efficient trafficking of
fatty acid stored in CLD into ER lumen (Yang et al., 1995).
Decreased TG accumulation in the sER, coupled with increased
accumulation of CLD-TG, indicates defective lipid partitioning
between CLD and the ER in L-Ire1a-KO hepatocytes. Previous
studies established a pivotal role for MTP in facilitating accretion
of TG in the VLDL secretory pathway (Raabe et al., 1999).
Interestingly, Ire1a deletion caused proportionate decreases in
PDI expression and MTP activity (40%). Overexpression of
IRE1a, XBP1s, or PDI all completely restored PDI levels and
MTP activity and significantly increased TG secretion in Ire1a-
deleted hepatocytes. Thus, transcriptional regulation of PDI is
a key mechanism whereby IRE1a-XPB1s regulates VLDL
assembly. However, overexpresson of PDI only partially comple-
mented the TG secretion defect in L-Ire1a-KO hepatocytes, sug-
gesting that IRE1a may increase TG-rich VLDL assembly
through an additional XBP1s-dependent but MTP-PDI-indepen-
dent mechanism(s).
Despite the reduced secretion of TG-rich VLDL particles, rates
of apoB secretion were not altered and degradation of apoB100
was not increased in L-Ire1a-KO hepatocytes under theOA-sup-
plemented experimental conditions employed in this study.
These observations suggest that the residual MTP activity
(60% of full activity) in L-Ire1a-KO hepatocytes is sufficient to
support cotranslational lipidation of apoB100 and prevent its
degradation, a key component of the first step of VLDL assembly
which is crucial for apoB secretion. In contrast, decreased MTP
activity mainly affected the second step of VLDL assembly in
L-Ire1a-KO hepatocytes, which involves bulk TG addition to
primordial VLDL particles. These findings are consistent with
the observation that Mtp deletion did not affect apoB48 secre-
tion, but the apoB48 was secreted only as lipid-poor particlesc.
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Figure 6. Overexpression of PDI, but Not MTP, Promotes TG Secretion in Ire1a Deleted Hepatocytes
(A) PDI expression is reduced in L Ire1a KO livers. Relative gene expression was normalized to actin mRNA levels, and values are compared tomRNA levels from
L Ire1a Het mice. *p < 0.05 versus L Ire1a Het.
(B and C) Adenovirus mediated overexpression of XBP1s increases PDI expression. (B) Values are relative to mRNA levels of L Ire1a KO hepatocytes infected
with adenovirus expressing GFP. (C) PDI andMTP protein levels weremeasured at 48 hr after infection of hepatocyteswith adenovirus expressing GFP (Ad GFP),
XBP1s (Ad XBP1s), MTP (Ad MTP), PDI (Ad PDI), or mutant PDI (Ad PDIMu). Actin was used as a loading control.
(D and E) Overexpression of PDI restores MTP activity and promotes hepatic TG secretion in L Ire1a Het hepatocytes. (D) TG synthesis and secretion rates were
measured at 48 hr after infection with the indicated adenoviruses (n = 6). *p < 0.05 versus Ad PDI or mutant PDI Ad PDIMu; **p < 0.05 versus Ad XBP1s. (E) MTP
activity was measured in each sample of (D). *p < 0.05 versus Ad PDI or Ad PDIMu.
(F H) XBP1 knockdown decreases PDI levels, MTP activity, and TG secretion in hepatocytes. (F) XBP1 and PDI levels were measured in hepatocytes transfected
with control siRNA or XBP1 siRNA. (G) MTP activity was measured in hepatocytes transfected with above siRNAs (n = 6). **p < 0.05 versus control. (H) TG
synthesis and secretion were measured in hepatocytes transfected with above siRNAs (n = 6). **p < 0.05 versus control.
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IRE1a Regulates Hepatic VLDL Assembly and Secretion(Rustaeus et al., 1998). The secretion of apoB100 was more
susceptible to alterations in MTP activity than that of apoB48
both in vitro (Kulinski et al., 2002) and in vivo (Chen et al.,
2008). Since apoB100 represents only a small proportion of the
total secreted apoB molecules, the precise effect of Ire1a dele-
tion on apoB100 secretion alone will require future studies using
genetically engineered mice that produce exclusively apoB100
from the apoB gene (Hirano et al., 1996).
IRE1a initiates production of XBP1s that is a potent transcrip-
tion factor that regulates expression of a wide range of ER
homeostatic genes. Disruption of XBP1 in secretory cells
profoundly reduces secretory functions of those cells (Hetz,
2012). Deletion ofXbp1 in the liverwas reported to cause a defect
in hepatic lipogenesis (Lee et al., 2008). However, lipogenic
activity was not altered in L-Ire1a-KO hepatocytes. There
are several possibilities that might account for the discrepant
phenotypes between Ire1a- and Xbp1-deleted mice. First,
albumin-promoter-driven CRE deletion of Ire1a may not be as
complete as Mx1-promoter-driven CRE recombinase (Mx1-
CRE). Residual XBP1s may sustain some functions of XBP1s in
hepatocytes. Second, Mx1-CRE-mediated deletion of Xbp1
occurs in multiple cell types in the liver, including Kupffer cells
and stellate cells (Ku¨hn et al., 1995). Inactivation of Xbp1 in
Kupffer cells may contribute to the impaired lipogenesis
observed in Xbp1-deleted hepatocytes because Kupffer cells
can affect lipogenesis in hepatocytes and even contribute to
diet-induced hepatosteatosis (Huang et al., 2010). In fact, we
did observe decreased expression of hepatic lipogenic genes
in Mx1-CRE Ire1a-deleted mice (S.W. and R.J.K., unpublished
data). Third, loss of XBP1 causes hyperactivation of IRE1a (Lee
et al., 2008) that can activate downstream signaling pathways
or mediate mRNA degradation to further complicate the pheno-
type observed in Mx1-CRE Xbp1 mice (Zhang and Kaufman,
2008). Regardless, both our XBP1s-complementation and
XBP1-knockdown experiments in primary hepatocytes support
the notion that XBP1 is the major determinant in the IRE1a
pathway that regulates TG-rich VLDL assembly.
Previous studies have documented a requirement for the
IRE1a-XBP1 pathway to expand the ER during differentiation
of cells that secrete large amounts of proteins (Hetz, 2012).
Recent studies have also implicated IRE1a in mRNA degrada-
tion, such as insulin mRNA in a pancreatic b cell line (Lipson
et al., 2006), and IRE1b in degradation of MTPmRNA in intestinal
epithelial cells to limit chylomicron production (Iqbal et al., 2008),
suggesting a physiological role for IRE1b in lipid metabolism.
Here, we demonstrate a unique physiological requirement for
IRE1a in metabolic regulation of lipid homeostasis by regulating
expression of PDI, an MTP chaperone, in response to metabolic
stress. Thus, it is of great interest to understand the role of the
IRE1a-XBP1-PDI pathway in development of dyslipidemia and
hepatosteatosis under pathophysiological conditions such as
obesity and diabetes.
In summary, we identified a specific role for IRE1a in regulating
TG-rich VLDL assembly and plasma lipid levels. The regulatory
mechanism requires XBP1s-PDI that increases MTP activity
for efficient TG partitioning into the ER lumen to provide
TG substrates for VLDL assembly. Thus, manipulation of the
IRE1a-XBP1 pathway may provide a unique approach to treat
hyperlipidemia.484 Cell Metabolism 16, 473–486, October 3, 2012 ª2012 Elsevier InEXPERIMENTAL PROCEDURES
Mice
All protocols for animal use were reviewed and approved by the Committee on
Use and Care of Animals at the University of Michigan and Sanford Burnham
Medical Research Institute. L Ire1a KO mice were generated and bred as
described (Zhang et al., 2011). All the transgenic mice in this study were back
crossed to C57/Bl6 background at least six generations. For long fasting
experiments, food was removed from mice overnight (16 hr) before sacrifice.
A HFD (TD. 89247, Harlan Teklad; Madison, WI) was given for increasing
periods of time, and mice were sacrificed after a 4 hr fast.
Plasma Parameters and Hepatic MTP Activity
Plasma levels of TG, ketone body, free cholesterol, CE, and fatty acid were
determined using EnzyChromTM Triglyceride and ketone body Assay Kit
(Bioassay, Hayward, CA), Free Cholesterol E, Cholesterol E assay kit, and
NEFA C commercial kit (Wako Chemicals GmbH). For lipoprotein analysis,
plasma was fractioned by FPLC using a Superose 6 column. The rates of
VLDL TG secretion were measured after mice were intravenously injected
with tyloxapol (500 mg/kg body weight) after 6 hr fasting. The Roar MTP
activity assay kit was used for MTP activity according to the manufacturer’s
instruction.
RNA Isolation and Quantitative PCR Analysis
Total RNAs were isolated using Trizol reagent (Life Technologies, Inc.
Carlsbad, California). cDNA was synthesized using iScript Reverse Transcrip
tion Supermix (Bio Rad, Hercules, CA). All primers from IDT (Coralville, IA) are
listed in Table S2.
Protein Isolation and Western Blotting
Proteins were extracted using RIPA buffer, resolved by SDS PAGE gels
(Bio Rad, Hercules, CA), and electroblotted onto PVDF membranes blocked
with nonfat milk. Membranes were incubated with different primary antibodies
(Table S3) followed by incubation with HRP secondary antibody or infrared
labeled antibody. Blots were analyzed by ImageJ (NIH) or quantified by
Odyssey Imager (LI Cor Biosciences, Lincoln, Nebraska).
Pulse-Chase Analysis of apoB, VLDL-TG Secretion, and Fatty Acid
Oxidation in Primary Hepatocytes
Hepatocytes were isolated as described (Chen et al., 2010). Cells were starved
20 min with Met and Cys free media followed by 20 min chase with [35S] Met/
Cys. After chase, every 20 min up to 60 min, samples were collected and har
vested for IP with apoB antibody. Labeled apoB immunocomplexes were
resolved by SDS PAGE and exposed to a phosphoimager screen. Quantifica
tion was performed using ImageJ. TG synthesis and secretion was measured
in hepatocytes incubated with [3H] glycerol (1 mCi/ml) for 3 hr. Labeled TG was
isolated from both cells and media, separated by TLC, and analyzed by
scintillation counting. Fatty acid oxidation was measured as described
(Purushotham et al., 2009).
Density Gradient Analysis of Lipoprotein from Primary Hepatocytes
and ER Lumen
Hepatocytes were exposed to 140 mCi/ml [35S] with 0.4 mM OA for 4 hr. The
labeledmedia or ER luminal contents released by 0.1MNa2CO3were adjusted
to 1.25 g/ml using KBr and layered below the salt solutions with density of
1.063 g/ml, 1.019 g/ml, and 1.006 g/ml followed by an ultracentrifugation.
Eleven fractions were isolated and analyzed as described for the pulse chase
experiments.
Isolation of rER and sER from Livers
The rER and sERwere isolated as described (Gilchrist et al., 2006). Livers were
homogenized in 0.25 M sucrose followed by centrifugation at 6,000 rpm. The
supernatant was centrifuged at 25,000 rpm for 7 min followed by another ultra
centrifugation at 55,000 rpm. The pellets were resuspended in 1.85 M sucrose
and adjusted to 1.37 M sucrose, which were laid to a step gradient containing
1.0 M, 0.8 M, and 0.6 M sucrose. The pellet rER fraction and the loading
zone sER fraction were collected. 2D gel was performed by Kendrick Labsc.
Cell Metabolism
IRE1a Regulates Hepatic VLDL Assembly and Secretion(Madison, WI), and mass spectroscopy was performed by the Protein Core
Facility at the Columbia University College of Physicians and Surgeons.
Hepatic Lipidomic Analysis
FAMEs were analyzed by GC by the lipidomics core at the Nutrition Obesity
Research Center at the University of Michigan.
Statistical Analysis
Data in the figures are presented with means ± SEM applying the unpaired
two tailed t test. p < 0.05 was considered a significant difference.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and three tables and can be
found with this article at http://dx.doi.org/10.1016/j.cmet.2012.09.003.
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